Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Changes in Equity

v3.19.1
Unaudited Condensed Consolidated Statements of Changes in Equity - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Deficit
Statutory Reserve
Accumulated Other Comprehensive Loss
Non-controlling Interest
Total
Beginning balance at Dec. 31, 2017 $ 7,028 $ 11,490,285 $ (3,517,654) $ 6,578 $ (91,994) $ (585,394) $ 7,308,849
Beginning balance, Shares at Dec. 31, 2017 70,278,622            
Treasury stock purchase       $ (522,500)         (522,500)
Treasury stock purchase, Shares     (520,000)          
Stock-based compensation   526,348           526,348
Foreign currency translation adjustment           52,678 160 52,838
Net loss for the year       (1,481,579)     (69,390) (1,550,969)
Ending balance at Mar. 31, 2018 $ 7,028 12,016,633 $ (522,500) (4,999,233) 6,578 (39,316) (654,624) 5,814,566
Ending balance, Shares at Mar. 31, 2018 70,278,622   (520,000)          
Beginning balance at Dec. 31, 2018 $ 7,383 24,153,378 $ (522,500) (11,291,776) 6,578 (236,860) (862,200) 11,254,003
Beginning balance, Shares at Dec. 31, 2018 73,830,751   (520,000)          
Stock-based compensation   2,272,747           2,272,747
Foreign currency translation adjustment           44,680 (1,198) 43,482
Issuance of common stock upon cashless exercise of stock options $ 35 (35)            
Issuance of common stock upon cashless exercise of stock options, Shares 350,856              
Issuance of common stock upon exercise of warrants   $ 16 (16)            
Issuance of common stock upon exercise of warrants, Shares   158,932              
Net loss for the year       (4,405,816)     (99,113) (4,504,929)
Ending balance at Mar. 31, 2019 $ 7,434 $ 26,426,074 $ (522,500) $ (15,697,592) $ 6,578 $ (192,180) $ (962,511) $ 9,065,303
Ending balance, Shares at Mar. 31, 2019   74,340,539   (520,000)